Table 2 Primary screening (antimicrobial activity of SCJ isolate) by the double-layer method on four culture media (Bennett, ISP1, ISP2 and GYEA).
Test strains | SCJ isolate | |||
|---|---|---|---|---|
Bennettc | ISP1c | ISP22a | GYEAb | |
Escherichia coli ATCC 25,922 | − | 38 ± 2.16 | 56.33 ± 4.50 | − |
Staphylococcus aureus CECT 976 | 25.5 ± 4.5 | 31 ± 1 | 31 ± 0.82 | 30.33 ± 2.87 |
Staphylococcus aureus ATCC 25,923 | − | 31.67 ± 3.40 | 37.33 ± 1.89 | 51.5 ± 0.5 |
Bacillus cereus ATCC 14,579 | − | 31 ± 2.16 | 57.68 ± 4.11 | 51.67 ± 3.86 |
Pseudomonas aeruginosa ATCC 27,853 | − | − | 34.67 ± 4.11 | 30.67 ± 1.70 |
Clinical Enterococcus | 28.33 ± 1.70 | − | − | 30.33 ± 3.09 |
Clinical Enterobacter | − | 27.5 ± 3.5 | 45 ± 2.5 | 38.67 ± 2.87 |
Clinical Staphylococcus aureus | 25.5 ± 4.5 | 31 ± 1 | 31 ± 0.82 | 30.33 ± 2.87 |
Clinical Proteus mirabilis | 32 ± 2.16 | − | 32 ± 1.63 | − |
Clinical Proteus vulgaris | − | − | 41 ± 0.82 | − |
Clinical Neisseria gonorrhea | 34.67 ± 2.49 | 29 ± 5.10 | 49.67 ± 4.50 | 40.33 ± 1.25 |
Clinical Escherichia coli | − | 38 ± 2.16 | 56.33 ± 4.49 | − |
Clinical Staphylococcus epidemidis | 17.5 ± 0.71 | 9.5 ± 0.71 | 19 ± 1.41 | 29 ± 1.41 |
Candida albicans ATTC 60,193 | − | − | 57 ± 2.16 | − |
Fusarium sp. MN944571 | − | − | 26.5 ± 0.71 | − |
Fusarium sp. MN944573 | − | − | 24.5 ± 0.71 | − |
Fusarium sp. MN944574 | − | − | 31 ± 1.41 | − |
Fusarium sp. MN944577 | − | − | 41 ± 1.41 | − |
